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ABSTRACT
Background Patients diagnosed with high-
grade gliomas experience a varying and complex
symptom burden, and face a high mortality rate.
As a consequence, patients with high-grade
gliomas and their caregivers have imminent and
changing rehabilitative and supportive care
needs.
Objectives To give a detailed overview of non-
pharmacological rehabilitative and supportive
care interventions for patients with high-grade
gliomas and/or their caregivers, and provide an
appraisal of the methodological quality of these
studies.
Method PubMed, Cumulative Index of Nursing
and Allied Health Literature and Embase were
searched for literature published from 1995 to
May 2013. Data from eight studies were
reviewed for substantive methods and results.
Methodological quality was described and
assessed using the scoring system for appraising
mixed methods research and concomitantly
appraising qualitative, quantitative and mixed
methods primary studies in mixed study reviews.
Results The search yielded 914 unique
publications, of which 9 were classified eligible
for this review. There is preliminary evidence that
cognitive group therapy improves memory skills
in patients with high-grade gliomas, early
physical training improves functional outcome
and massage therapy reduces stress. Patients and
caregivers found that telephone follow-up and a
specialist nurse function was an effective and
useful way to achieve information and support.
Finally, psycho-education increased feelings of
mastery among caregivers.
Conclusions As evidence is beginning to
emerge, there is a need for well-designed
longitudinal and randomised controlled trials of
non-pharmacological interventions in high-grade
glioma patients and their caregivers in order to
develop clinical guidelines for supportive and
rehabilitative approaches in this unique
population.
INTRODUCTION
High-grade glioma (HGG) is the most
malignant type of brain tumour (BT)
occurring most frequently in people aged
45–70.1 Treated with optimal therapy, the
median survival is 12–15 months with a
5-year survival of 10%.2 Patients with
HGG experience a high symptom burden
related to the disease and the surgical pro-
cedures and medical treatments.3 4
Different types of cerebral symptoms and
complications may occur, including global
cerebral symptoms (fatigue, nausea, head-
ache, confusion) focal symptoms (hemipar-
esis, seizures, speech difficulties),
neurocognitive deficits (impaired attention,
concentration difficulties, reduced short-
term memory, personality changes) and
emotional symptoms (depression, anxiety,
stress).5–9 As a consequence, patients with
HGG and their caregivers have a number
of rehabilitative and supportive care needs.
The literature recommends that future
intervention studies include individually
tailored communication and specialist
support10–12 to relieve emotional distress
in patients with gliomas13 and stress
among caregivers.14 However, little atten-
tion has been paid to non-pharmacological
rehabilitative and supportive care interven-
tions targeted patients with HGG and/or
their caregivers.15 A recent Cochrane lit-
erature review16 was unable to identify any
randomised controlled trials (RCT) or con-
trolled clinical trials of multidisciplinary
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rehabilitation interventions in adults after primary BT
treatment.16 The majority of studies include participants
with different subtypes of BT; however, tumour pro-
gression varies depending on tumour type. HGG is a
rapidly progressive life-threatening disease, while other
subgroups of BT progress more slowly. This is sup-
ported by investigators who underpin the importance of
research on potential differences in needs among the
heterogeneous population of patients with BT.17 18
Presently, there are no evidence-based rehabilitative and
supportive care guidelines that aim to reduce loss of
cognition, function and quality of life (QOL). To our
knowledge, this is the first systematic literature review
that gives a detailed overview of rehabilitative and sup-
portive care intervention studies in patients with HGG
and/or their caregivers with a systematic appraisal of the
methodological quality of each publication.
METHODS
This systematic literature search reviews non-
pharmacological rehabilitative and supportive care
interventions in patients with HGG and their care-
givers. Data regarding population, study design, inter-
vention and main results are extracted, synthesised
and discussed. The selected publications are appraised
for methodological quality. Lastly, implications for
future research and conclusions are presented.
Literature search
The study population includes patients with HGG and/
or their caregivers in non-pharmacological rehabilitative
and supportive care intervention studies. Searches were
performed in PubMed, Cumulative Index of Nursing
and Allied Health Literature (CINAHL) and Embase.
Combinations of the following ‘Medical Subject
Heading’ (MeSH) terms and free text terms were used:
‘brain cancer’, ‘brain neoplasms’, ‘brain tumor’, ‘high-
grade glioma’, ‘malignant glioma’, ‘rehabilitation’,
‘training’, ‘expectations’, ‘needs’, ‘quality of life’, ‘sup-
portive care’, ‘intervention’, ‘program’, ‘intervention
studies’, ‘caregiver’, ‘spouse’, ‘relative’ and ‘next of kin’.
The search strategy is illustrated in figure 1. The full
search strategy including search terms used for each
database is available and may be requested by contacting
the corresponding author (KP). Reference Manager
Software program was used to identify duplicates. The
search was limited to English-, Danish-, Norwegian- and
Swedish-language publications published from 1995 to
May 2013. The systematic literature search was guided
by the PRISMA guidelines—preferred reporting items
for systematic reviews and meta-analyses developed by
Cochrane Collaboration.19
Inclusion and exclusion criteria
Publications included are randomised and non-
randomised controlled trials of unidisciplinary or
multidisciplinary non-pharmacological rehabilitative
and/or supportive care interventions in patients with
HGG and/or their caregivers. Studies with different
subtypes of BT are included only if statistical analysis
was performed in the HGG population. Trials study-
ing medical and pharmaceutical treatments are
excluded from this review.
Data extraction and quality assessment
Information regarding the population (sample size,
age and attrition), the study design (focus and time of
enrolment), the intervention (context, type, mode,
duration, frequency, length and adherence) and main
results were extracted and systemised using NVivo
software program (see online supplementary table
S1).20 Assessment of methodological quality and
scoring of each publication was carried out independ-
ently by two researchers (KP and MJA). There was no
discrepancy between the raters’ scores. The online
supplementary table S2 shows an evaluation of the
methodological quality of each publication.
Methodological quality was assessed using the scoring
system for appraising mixed methods research and
concomitantly appraising qualitative, quantitative and
mixed methods primary studies in mixed study
reviews.21 Methodological quality for the qualitative
studies was assessed for the presence or absence of the
following criteria: a qualitative objective or question,
appropriate qualitative approach or design or method,
a description of the context, a description of partici-
pants and justification of sampling, a description of
qualitative data and a discussion of researchers’ reflex-
ivity collection and analysis. Methodological quality
for the quantitative experimental studies was
appraised for the presence or absence of the following
criteria: an appropriate sequence generation and/or
randomisation, allocation concealment and/or blind-
ing, and presentation of complete outcome data and/
or low withdrawal/dropout. For each criterion, the
presence or absence is scored 1 or 0, respectively. The
quality score is calculated as a percentage: (number of
‘presence’ responses divided by the number of rele-
vant criteria)×100. A further descriptive and detailed
critical appraisal of methodological quality is
presented.
Ethics
This systematic review is part of a larger study, which
is registered at the Research Ethics Committees at the
Regional capital in Copenhagen, Denmark (33460),
and the Danish Data Protection Agency
(2007-58-0015/30-0758).
RESULTS
A systematic search was carried out by an information
specialist and the primary investigator (KP) in June
2013. The search resulted in 748 hits in PubMed, 114
hits in CINAHL and 52 hits in Embase and is sche-
matically outlined in figure 1. No duplicates were
identified, resulting in 914 unique titles. The titles
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and/or abstracts of the 914 publications were reviewed
by the primary investigator (KP), and 894 publications
were excluded. Two researchers (KP and MJA)
reviewed 20 full manuscripts, which appeared poten-
tially relevant, and 11 were excluded. Nine publica-
tions describing eight different interventions met the
inclusion criteria.22–30 Sardell et al’s26 mixed BT
population study was included because all 45 patients
(n=43 HGG; n=1 primitive neuroectodermal
tumour; n=1 oligoastrocytoma) received primary
therapy for high-grade malignancy.
Study characteristics
The online supplementary table S1 describes popula-
tions studied, interventions employed and main
results.
The nine publications were published in seven differ-
ent scientific journals between 2000 and 2012, the
majority being published within the last 5 years.
The time of patient and/or caregiver enrolment to the
interventions varied in the studies, from time of
diagnosis to late stages of the disease. Four studies were
initiated at time of diagnosis,24 25 27 28 30 one after hos-
pital discharge23 and two studies 15–16 months after
diagnosis.22 26 All interventions were supervised, seven
were carried out individually23–30 and one intervention
was a group intervention.22 Six studies were unidisciplin-
ary22 23 26–30 and two were multidisciplinary as they
combined physical training with occupational and
speech therapy, respectively.24 25
Populations studied
The studies primarily included patients diagnosed
with HGG. However, one publication included only
caregivers,29 and one included both patients and their
caregivers.27 28 This was the only intervention that
continued to intervene with caregivers after the
patient died.27 28 The age of the patients ranged from
23 to 79 years (mean 55.8). The age of the caregivers
was not reported. Sample sizes ranged from 11 to 121
participants (mean 50.8). The demographic character-
istics of the participants were included in all but one
Figure 1 PRISMA flow diagram.
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study30 and not outlined according to subgroup diag-
noses in two studies.23 24
Intervention and outcome characteristics
Nine publications (eight interventions) reported the
results of non-pharmacological rehabilitative and/or
supportive care interventions in patients with HGG
and/or their caregivers22–30 (see online supplementary
table S1). Hassler et al22 examined the effect of super-
vised cognitive group training in patients with HGG,
Pace et al,23 Geler-Kulcu et al24 and Bartolo et al25
studied the effect of supervised physical training in
patients with HGG and Sardell et al,26 Spetz et al27 28
and Boele et al29 (four publications) tested nurse-led
telephone follow-up (NTF), a specialist nurse (SN) func-
tion in patients and caregivers and psycho-education in
caregivers, respectively. Keir30 examined the effect of
massage therapy among HGG patients.
Five interventions were conducted in a hospital
setting,22 24 25 29 30 one of the physical training pro-
grammes was carried out as a home programme23 and
two follow-up studies took place in a combination of
a home and hospital setting.26–28 The length of the
interventions varied considerably, from 2 weeks to
comprise the entire disease and treatment trajectory
until post bereavement. The duration of the interven-
tions was between 6 and 57 h (median
27.7);22 24 29 30 however, it was not specified for
three supportive care interventions.26–28
Hassler et al’s22 cognitive group training pro-
gramme found significant improvement in memory
skills measured by verbal memory total learning
(p=0.04) and no change in verbal memory delayed
recall (p=0.11), psychomotor speed (p=0.22), sus-
tained attention (p=0.17) and verbal fluency
(p=0.29). Pace et al23 introduced a home rehabilita-
tion programme with individual physical training and
reported clinical improvements for the BT group on
KPS and The Bartel Index (BI) measuring Activities of
Daily Living. Among these patients, a significant
improvement in median BI (p=0.001) and median
KPS (p=0.001) was reported. Subgroup data showed
no difference between histological subgroups;
however, a functional gain (not specified) was
observed in 26% of the HGG population (N=62).
Geler-Kulcu et al’s24 trial with physical and occupa-
tional therapy compared BT patients postoperatively
and patients with stroke. Both groups improved in
Motor Assessment Scale (MAS) (p=0.025/p=0.002),
Postural Assessment Scale for Stroke (PASS)
(p=0.002/p=0.002), Berg Balance Scale (BBS)
(p=0.011/p=0.109) and Functional Impairment
Measurement (FIM-mobility) (p=0.043/p=0.007).
No statistical difference between BT subgroups or
between the group of BT patients and stroke patients
was observed in any measurement (MAS p=0.718,
PASS p=0.817, BBS p=0.109, FIM-mobility
p=0.660). Bartolo et al25 found similar results in a
physical training and speech therapy intervention in a
BT group and a stroke group. All outcome measures
improved at postintervention for both groups
(p<0.001), though without statistical differences
between groups. A subgroup analysis (meningioma,
HGG and stroke) revealed that patients with meningi-
oma achieved better independence in activities of
daily living (p=0.02) and mobility (p=0.04) com-
pared with the HGG and stroke group. However, the
total FIM scores and other clinical scales revealed no
differences between the subgroups. There were four
different types of supportive care interventions.26–29
Sardell et al26 showed that a monthly and ongoing
NTF of patients with HGG was an effective alterna-
tive to conventional clinic follow-up with face-to-face
consultation. Patient satisfaction was high and the
numbers of unscheduled clinic visits were minimised
to include acute problems as the NTF assisted the
patients with a variety of other problems by tele-
phone. A qualitative study carried out by Spetz
et al27 28 included both patients and caregivers and
showed that an SN role was a useful way to provide
information and support. The SN function increased
the family’s autonomy and facilitated decision making
within the family. The SN was a resource for the
patients, the caregivers and the entire family. Boele
et al’s29 RCT found that a psycho-education interven-
tion in caregivers during a 6-week period increased
feelings of mastery (p=0.021). Keir’s 4-week massage
therapy intervention reduced stress between weeks 2
and 3 (p=0.010) and improved emotional well-being
(p≤0.001), BT concerns (p≤0.013) and social/family
well-being (p≤0.024) at post-testing. All participants
were below their baseline stress score 1 week after the
massage intervention was completed.30
Description of study methodological quality
Systematic methodological ratings of all the included
nine papers, with respect to each relevant criterion,
are shown in the online supplementary table S2. Spetz
et al’s27 28 intervention study applied a qualitative
approach to explore the effect of the SN function. It
fulfilled the methodological quality criteria by 100%.
The study formulated a qualitative objective, applied
an appropriate qualitative method, described the
context, the participants and made a justification of
sampling. Further, appropriate qualitative data collec-
tion and analysis was carried out and the researcher’s
reflexivity was described. Seven intervention studies
applied quantitative experimental designs22–26 29 30;
the neurocognitive training study,22 the home rehabili-
tation programme,23 the two physical training trials
comparing BT patients and stroke patients,24 25 the
evaluation of NTF,26 the psycho-education study29
and the massage study.30 All fulfilled 33.3% of the
quality criteria as they only presented a complete
outcome data and/or low dropout rate, except for the
psycho-education study that scored 33.3%, as it
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fulfilled the criteria of applying an appropriate
randomisation.29
Further details regarding the study design, inclusion
and exclusion criteria, risk of bias, attrition rates and
adverse events are described in the following. All
studies were designed as controlled interventions
trials. One study published in two papers applied a
qualitative design (interview, observation).27 28 The
remaining seven studies used quantitative designs
(RCT, case–control, clinical controlled pilot trials,
comparative trials).22–26 30 All interventions carried
out pre-post measurements.
Three interventions were conducted during the
early stage of the disease.23–25
Statistical methods and p values were presented in
all but two studies.26–28 Validated measurement out-
comes were applied in all studies, except the qualita-
tive study.27 28 All interventions are described in detail
in such a way that would allow duplication of the
intervention design, except the home training study.23
All nine papers defined an inclusion and exclusion
criteria. Exclusions were often due to patients/care-
givers speaking a language unfamiliar to the investiga-
tors or participants being unable to complete the
questionnaires. Aside from these systematic exclusions,
there was a range of other exclusion criteria related to
the patient’s disease status and level of physical and
cognitive function. The cognitive training study
included only patients with a KPS between 80 and
100%, without aphasia and without evidence of
tumour recurrence after having received standard
oncological treatment.22 A high performance status
was also a criterion for inclusion in the massage study
and the SN follow-up.27 28 30 Patients with communi-
cation or cognitive problems were excluded from the
NTF study,26 and patient/caregiver groups were
excluded if expected survival was less than 3
months.29 30 Three studies reduced risk of bias by
applying a RCT design29 or by including a control
group with a one-to-one match.24 25 One of these
studies excluded subtypes of BT in order to maintain
a homogeneous group of participants.25 The remain-
ing six studies were conducted without a control
group.22 23 26–28 30 Spetz et al27 28 concluded that a
SN function relies on the person’s experience and per-
sonal qualities and therefore the function could not
be regarded as separate from the person performing it,
and Sardell et al26 concluded that the study partici-
pants only reflected a selected group of patients.
Attrition rate was low for all studies ranging from
0% to 12.5%, except Boele et al’s psycho-education
intervention reported 51.6% and 32% attrition in the
intervention and control groups, respectively. Boele
et al concluded that a six-session intervention with a
psychologist and/or four questionnaires at five test
points may have been too demanding for the care-
givers. Attrition was not reported in the home training
study.23 An adverse event was reported in the massage
study as one patient developed shingles during the
intervention and dropped out.30 An investigation
revealed that this event was unrelated to the massage
intervention. Sardell et al26 argued that it was reason-
able to assume that HGG patients can be followed up
by telephone without adversely affective overall care
or survival. Spetz et al27 elaborated on the risk of the
SN being too personally engaged in the relationship
with the families that may negatively affect the rela-
tionship within the family. Moreover, the authors
report that two caregivers abstained from participating
in the last interview, which could reflect caregiver dis-
satisfaction with the intervention.28 There were no
contraindications to physical training reported.25 The
great diversity of age, gender and educational back-
ground in the small sample size enabled patients to
avoid stressful comparisons and competition in the
cognitive training programme, and no adverse events
were reported from the cognitive training study.22
Three studies did not report adverse events.23 24 29
DISCUSSION
This systematic review identified the relatively few
controlled trials of unidisciplinary or multidisciplinary
non-pharmacological rehabilitative and/or supportive
care interventions in patients with HGG and/or their
caregivers. The eight studies were found to be diverse
in purpose, study design and of low methodological
quality. Methodological limitations of the reviewed
studies include small sample sizes, biases in study
design and few subgroup analyses. However, there is
initial evidence that cognitive and physical training
and psychosocial support benefit HGG patients and/
or their caregivers.
Rehabilitative interventions
Cognitive training
Hassler et al22 found that a neurocognitive group
training programme improved memory skills.
Late-stage patients with a KPS of 80–100 were
enrolled, and it is yet to be explored whether such a
programme can be beneficial to HGG patients with a
KPS ≤80. No control group or follow-up measure-
ments after 12 weeks were conducted, leaving the lon-
gitudinal effects of cognitive training unknown among
HGG patients.
Based on previous research, there is preliminary evi-
dence to suggest that cognitive training among
patients with low-grade gliomas (LGG) improves cog-
nitive status.31 This RCT study among patients with
LGG (N=140) provides initial evidence of a salutary
effect on short-term cognitive complaints and on
longer-term cognitive performance and mental
fatique.31 Further, an internet-based cognitive rehabili-
tation programme in patients with BT proved to be a
convenient and flexible alternative to in-clinic
programmes.32
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Physical training
This systematic review found that early and individually
tailored physical training (within weeks after surgery)
resulted in significant functional gain for HGG patients.
However, functional and neurological gains in the
weeks after surgery may be explained by the neurosurgi-
cal intervention alone. Geler-Kulcu et al’s24 findings
were inconclusive regarding the effect of physical train-
ing and occupational therapy in HGG patients as only
nine patients with HGG were included.
No physical training studies reported adverse events
as a direct result of testing or training. In two studies,
functional outcomes were not significantly different in
patients with benign tumours versus malignant tumours
or primary versus metastatic BTs or BT patients com-
pared with patients with stroke.23 24 However, in a third
study, meningioma patients achieved a greater functional
gain (independence in activities of daily living and
mobility) compared with patients with HGG or
stroke.25 Evidence for the benefit of physical training
among HGG patients is emerging. However, this evi-
dence justifies physical training before the adjuvant
therapy as two out of three studies included patients
before radiotherapy and chemotherapy was adminis-
tered.24 25 Three retrospective studies conclude that
patients with BT achieve improved functional outcomes
from inpatient rehabilitation.33–35 Consistent with this,
a comparative study of inpatient rehabilitation among
patients with BT and patients with traumatic brain
injury patients showed functional gains for both
groups.36 However, the absolute functional outcomes
were smaller in the BT group.
Supportive care interventions
Psychosocial support
In this systematic review, patient and caregivers’ need
for psychosocial support was met by applying differ-
ent psychosocial approaches. Psychosocial support
provided by a SN is of value for both patients and
their families,27 28 and telephone follow-up is a useful
strategy.26 Repeated counselling with a psychologist
improved QOL issues and mastery of caregivers.29
However, high attrition indicates that the programme
was too burdensome for the participants. Keir showed
that massage therapy reduces the feeling of stress.30 It
is not possible to estimate the effect of the massage
programme as there was no control group. It is
imperative that researchers are familiar with the
needs, preferences and interests of these patients and
their caregivers in order to design interventions that
would result in high adherence and low attrition. Two
previous reviews explored the needs of patients with
HGG and their family/caregivers,37 38 and presently
more evidence is being established.39
Methodological discussion
The strengths of the reviewed studies were that
patients with HGG and/or their caregivers generally
accept participation in interventions at various times
during the disease and treatment trajectory.
Interventions that aim to support the patient and/or
caregiver, improve cognitive or functional status and
reduce stress have high adherence. However, as par-
ticipation can be experienced as burdensome and
result in high attrition, careful ethical and methodo-
logical considerations are required. It has been
reported that attrition rates are usually high for sup-
portive care interventions in patients with HGG.40
Reasons for attrition were death, medical decline of
the patient or high caregiver burden.41 High attrition
was noted in the RCT that required the participants
to respond to four different questionnaires every
second month, five times in total.29 However, the
reason for high attrition in this RCT was not con-
firmed by the participants. Two studies were matched
case–control studies24 25 strengthening the evidence
of multidisciplinary interventions (combined physical
training with either occupational or speech therapy)
on functional outcomes. Further, strengths of the
reviewed studies include the use of validated measure-
ment outcomes, except in the qualitative study.27 28
However, the use of different questionnaires and mea-
surements makes it difficult to compare results.
The limitations of the reviewed studies are that they
are heterogeneous in many respects, which makes
them non-comparable. Sample sizes are small with
some studies including as few as 11 participants.22
This questions the validity and reliability of the statis-
tical analyses in the studies. Further study limitations
include lack of control groups and longitudinal
follow-up periods. Selection bias arises from the
exclusion of patients with low-performance
status22 27 28 30 or cognitive deficit and communica-
tion problems.26
The scoring system applied for methodological
quality needs to be further tested for reliability.21
However, a pilot study found it to be a promising
appraisal tool42 and it is presently used internation-
ally.43 Moreover, it provides transparency in how the
methodological quality was scored and readers can
review the decisions. Finally, an additional descriptive
methodological quality appraisal of the included
studies supplemented this tool.
CLINICAL AND RESEARCH IMPLICATIONS
Patients with HGG differ from other cancer diagnoses
because of progressive neurological deterioration
resulting in changing and complex symptoms along
the disease and treatment trajectory. A multidisciplin-
ary approach has the potential to meet the variety of
needs emerged from this life-threatening situation.
However, cognitive deficits, changes in personality,
lack of insight and loss of empathy may impair HGG
patients’ ability to participate actively in rehabilitative
and supportive care programmes. Therefore, it is
important that the interventions are tailored to the
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special needs of this group. New approaches, such as
internet-based approaches, might have the potential to
meet the needs of patients with HGG and their care-
givers.44 It is well known that decreased QOL is asso-
ciated with depression among patients with HGG.45
However, psychosocial support for patients with
HGG has not been the subject of much research,46
which is why future research should aim at maintain-
ing QOL. Studies that enrol patients during and after
oncological treatments are important as the adjuvant
treatment has a negative impact on functional capacity
among patients with HGG47 and reduced cardio-
respiratory fitness postoperatively.48 Further, treat-
ment with glucocorticoids causes muscle atrophy.49
From non-cancer clinical populations, it has shown
that resistance and endurance physical training can
reverse muscle atrophy.50 It is therefore interesting to
explore whether a similar effect can be achieved for
patients with HGG.
CONCLUSION
As evidence is beginning to emerge, there is a need
for well-designed longitudinal and randomised con-
trolled trials of non-pharmacological interventions in
patients with HGG and their caregivers. Despite the
methodological limitations of the included studies,
cognitive training, individual tailored physical training
programmes, psychosocial support/education and
massage therapy have positive outcomes for both
patients and their caregivers, are feasible and so far,
without risk for this group. Research is needed to
sustain this beginning evidence. To provide stronger
evidence, clinical controlled trials with longitudinal
designs focusing on cognitive and physical training as
well as supportive care are needed.
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